Intra-abdominal Infection Treatment Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Intra-abdominal Infection Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Chloramphenicol
Beta Lactums
Quinolones
Aminoglycosides
Others
Segment by Application
Intra-abdominal Abscess
Appendicitis
Diverticulitis
Diarrhea
Food Poisoning
Infection by Helicobacter Pylori
By Company
AstraZeneca
Merck
Pfizer
AtoxBio
Dainippon Sumitomo Pharma
Bayer
Bristol-Myers Squibb
Mylan Pharmaceuticals Inc.
Sun Pharmaceutical Industries, Inc.
Teva Pharmaceutical Industries
Dr. Reddy?s Laboratories
Roche Holding AG
GlaxoSmithKline
Sanofi
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
